Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A11343 | Pages: 376 | Charts: 61 | Tables: 273 |
OTC artificial tears market generated $4,379 million in 2020, and is projected to reach $6,399.43 million by 2028, growing at a CAGR of 4.94% from 2021 to 2028. Artificial tears also known as ocular lubricants are lubricating eye drops, which are formulated to provide relief from irritation, burning, discomfort, and dryness of the ocular surface. It maintains moisture at the outer surface of the eyes. Over-the-counter (OTC) artificial tears are the eye drops which are available without prescription.
[COVIDIMPACTSTATEMENT]
The growth of the global OTC artificial tears market is majorly driven by increase in geriatric population; rise in prevalence of eye diseases such as dry eye syndrome and allergic conjunctivitis; surge in demand for artificial tears products; and increase in investment in R&D activities by various healthcare companies. In addition, increase in number of eye surgeries, rise in awareness about management of dry eye syndrome, and initiatives taken by the government for the development & production of different novel OTC artificial tears propel the growth of the market. However, side effects associated with the OTC artificial tears such as blurred vision, redness around the eye, and skin rashes, are expected to restrict the OTC artificial tears market growth during the forecast period.
Get more information on this report : Request Sample Pages
The OTC artificial tears market is segmented into the product type, container type, formulation, application, distribution channel, and region. By product type, the market is divided into solution, ointment, emulsion, gel, spray solution, and suspensions. On the basis of container type, the market is fragmented into plastic single dose container, plastic multi-dose container, and spray. Further, plastic multi-dose container is bifurcated into preservative free system and preserved system. On the basis of spray, the market is divided into preservative free system and preserved system. By formulation, the market is differentiated into preservative based and non-preservative based. By application, the market is divided into dry eye syndrome, allergies, infections, UV and Blue light protection, contact lens moisture retention and others. On the basis of distribution channel, the market is fragmented into hospital pharmacies, drug stores and retail pharmacies and online pharmacies. Region wise, the OTC artificial tears market is analyzed across North America, Europe, Asia-Pacific, Middle East, North Africa and Rest of World.
[PRODUCTTYPEGRAPH]
Depending on the product type, the solution segment dominated the global OTC artificial tears market in 2020, and is anticipated to remain dominant during the forecast period, due to increase in demand for eye drops, surge in manufacturing of artificial tears for the treatment of dry eye diseases, and advancement in the R&D for novel ophthalmic product. However, the gel segment is expected to witness considerable growth during the forecast period due to increase in demand for eye gel and rise in number of key players for manufacturing combinational semisolid ophthalmic drug.
On the basis of distribution channel, the Drug Store & Retail Pharmacies segment exhibited the highest growth rate in 2020, and is anticipated to lead in the near future due to rise in prevalence of dry eye syndrome diseases, increase in number of geriatric population, and development in technology in the healthcare sector. However, the online pharmacies segment is expected to witness considerable growth during the forecast period, due to gradual increase in the process of digitalization, sales of drugs at low cost, as well as increase in awareness about eye health support.
[DISTRIBUTIONCHANNELGRAPH]
North America accounted for a major share in the OTC artificial tears market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of dry eye diseases, presence of advanced healthcare infrastructure, as well as surge in the demand for OTC artificial tears. Furthermore, rise in awareness about the prevention and treatment of dry eye disease, and increase in demand for advanced healthcare facilities contribute toward the growth of the market. Moreover, upsurge in R&D activities in the healthcare sector to develop novel products and presence of major players operating in the region fuel the growth of the market. However, Asia-Pacific is expected to register the highest CAGR of 6.0% from 2021 to 2028, due to rise in prevalence of eye disease such as allergic conjunctivitis, dry eye syndrome, increase in number of eye surgeries for cataract and glaucoma, and rise in awareness about management of dry eye.
The key players operating in the global market include AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.
[REGIONGRAPH]
Key Benefits For Stakeholders
Key Market Segments
By Product
By Container Type
By Formulation
By Application
By Distribution Channel
By Region
Key Market Players
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3:MARKET LANDSCAPE
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.PORTER'S FIVE FORCES ANALYSIS
3.3.1.Bargaining power of suppliers
3.3.2.Threat of new entrants
3.3.3.Threat of substitutes
3.3.4.Competitive rivalry
3.3.5.Bargaining power among buyers
3.4.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING 2019
3.5.MARKET DYNAMICS
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.IMPACT ANALYSIS OF COVID-19 ON MARKET
CHAPTER 4:OTC ARTIFICIAL TEARS MARKET BY PRODUCT TYPE
4.1.OVERVIEW
4.2.SOLUTION
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country
4.3.OINTMENT
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country
4.4.EMULSION
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country
4.5.GEL
4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country
4.6.SPRAY SOLUTION
4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market share analysis, by country
4.7.SUSPENSIONS
4.7.1.Key market trends, growth factors and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market share analysis, by country
CHAPTER 5:OTC ARTIFICIAL TEARS MARKET BY CONTAINER TYPE
5.1.OVERVIEW
5.2.PLASTIC SINGLE DOSE CONTAINER
5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.PLASTIC MULTI-DOSE CONTAINER
5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.3.4.Preservative-free system
5.3.4.1.Market size and forecast
5.3.5.Preserved Systems
5.3.5.1.Market size and forecast
5.4.SPRAY
5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.4.4.Preservative-free system
5.4.4.1.Market size and forecast
5.4.5.Preserved Systems
5.4.5.1.Market size and forecast
CHAPTER 6:OTC ARTIFICIAL TEARS MARKET BY FORMULATION
6.1.OVERVIEW
6.2.PRESERVATIVE BASED
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country
6.3.NON-PRESERVATIVE BASED
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country
CHAPTER 7:OTC ARTIFICIAL TEARS MARKET BY APPLICATION
7.1.OVERVIEW
7.2.DRY EYE SYNDROME
7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country
7.3.ALLERGIES
7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country
7.4.INFECTIONS
7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country
7.5.UV AND BLUE LIGHT PROTECTION
7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country
7.6.CONTACT LENS MOISTURE RETENTION
7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country
7.7.OTHERS
7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country
CHAPTER 8:OTC ARTIFICIAL TEARS MARKET BY DISTRIBUTION CHANNEL
8.1.OVERVIEW
8.2.HOSPITAL PHARMACIES
8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast, by region
8.2.3.Market share analysis, by country
8.3.DRUG STORE AND RETAIL PHARMACIES
8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast, by region
8.3.3.Market share analysis, by country
8.4.ONLINE PHARMACIES
8.4.1.Key market trends, growth factors and opportunities
8.4.2.Market size and forecast, by region
8.4.3.Market share analysis, by country
CHAPTER 9:OTC ARTIFICIAL TEARS MARKET BY REGION
9.1.OVERVIEW
9.2.NORTH AMERICA
9.2.1.Key market trends and opportunities
9.2.2.Market size and forecast, by product type
9.2.3.Market size and forecast, by container type
9.2.4.Market size and forecast, by formulation
9.2.5.Market size and forecast, by application
9.2.6.Market size and forecast, by distribution channel
9.2.7.Market size and forecast, by Country
9.2.8.U.S.
9.2.8.1.Market size and forecast, by product type
9.2.8.2.Market size and forecast, by container type
9.2.8.3.Market size and forecast, by formulation
9.2.8.4.Market size and forecast, by application
9.2.8.5.Market size and forecast, by distribution channel
9.2.9.Rest of North America
9.2.9.1.Market size and forecast, by product type
9.2.9.2.Market size and forecast, by container type
9.2.9.3.Market size and forecast, by formulation
9.2.9.4.Market size and forecast, by application
9.2.9.5.Market size and forecast, by distribution channel
9.3.EUROPE
9.3.1.Key market trends and opportunities
9.3.2.Market size and forecast, by product type
9.3.3.Market size and forecast, by container type
9.3.4.Market size and forecast, by formulation
9.3.5.Market size and forecast, by application
9.3.6.Market size and forecast, by distribution channel
9.3.7.Market size and forecast, by Country
9.3.8.UK
9.3.8.1.Market size and forecast, by product type
9.3.8.2.Market size and forecast, by container type
9.3.8.3.Market size and forecast, by formulation
9.3.8.4.Market size and forecast, by application
9.3.8.5.Market size and forecast, by distribution channel
9.3.9.Germany
9.3.9.1.Market size and forecast, by product type
9.3.9.2.Market size and forecast, by container type
9.3.9.3.Market size and forecast, by formulation
9.3.9.4.Market size and forecast, by application
9.3.9.5.Market size and forecast, by distribution channel
9.3.10.France
9.3.10.1.Market size and forecast, by product type
9.3.10.2.Market size and forecast, by container type
9.3.10.3.Market size and forecast, by formulation
9.3.10.4.Market size and forecast, by application
9.3.10.5.Market size and forecast, by distribution channel
9.3.11.Italy
9.3.11.1.Market size and forecast, by product type
9.3.11.2.Market size and forecast, by container type
9.3.11.3.Market size and forecast, by formulation
9.3.11.4.Market size and forecast, by application
9.3.11.5.Market size and forecast, by distribution channel
9.3.12.Spain
9.3.12.1.Market size and forecast, by product type
9.3.12.2.Market size and forecast, by container type
9.3.12.3.Market size and forecast, by formulation
9.3.12.4.Market size and forecast, by application
9.3.12.5.Market size and forecast, by distribution channel
9.3.13.Poland
9.3.13.1.Market size and forecast, by product type
9.3.13.2.Market size and forecast, by container type
9.3.13.3.Market size and forecast, by formulation
9.3.13.4.Market size and forecast, by application
9.3.13.5.Market size and forecast, by distribution channel
9.3.14.Rest of Europe
9.3.14.1.Market size and forecast, by product type
9.3.14.2.Market size and forecast, by container type
9.3.14.3.Market size and forecast, by formulation
9.3.14.4.Market size and forecast, by application
9.3.14.5.Market size and forecast, by distribution channel
9.4.ASIA-PACIFIC
9.4.1.Key market trends and opportunities
9.4.2.Market size and forecast, by product type
9.4.3.Market size and forecast, by container type
9.4.4.Market size and forecast, by formulation
9.4.5.Market size and forecast, by application
9.4.6.Market size and forecast, by distribution channel
9.4.7.Market size and forecast, by Country
9.4.8.Japan
9.4.8.1.Market size and forecast, by product type
9.4.8.2.Market size and forecast, by container type
9.4.8.3.Market size and forecast, by formulation
9.4.8.4.Market size and forecast, by application
9.4.8.5.Market size and forecast, by distribution channel
9.4.9.China
9.4.9.1.Market size and forecast, by product type
9.4.9.2.Market size and forecast, by container type
9.4.9.3.Market size and forecast, by formulation
9.4.9.4.Market size and forecast, by application
9.4.9.5.Market size and forecast, by distribution channel
9.4.10.India
9.4.10.1.Market size and forecast, by product type
9.4.10.2.Market size and forecast, by container type
9.4.10.3.Market size and forecast, by formulation
9.4.10.4.Market size and forecast, by application
9.4.10.5.Market size and forecast, by distribution channel
9.4.11.Malaysia
9.4.11.1.Market size and forecast, by product type
9.4.11.2.Market size and forecast, by container type
9.4.11.3.Market size and forecast, by formulation
9.4.11.4.Market size and forecast, by application
9.4.11.5.Market size and forecast, by distribution channel
9.4.12.Vietnam
9.4.12.1.Market size and forecast, by product type
9.4.12.2.Market size and forecast, by container type
9.4.12.3.Market size and forecast, by formulation
9.4.12.4.Market size and forecast, by application
9.4.12.5.Market size and forecast, by distribution channel
9.4.13.Thailand
9.4.13.1.Market size and forecast, by product type
9.4.13.2.Market size and forecast, by container type
9.4.13.3.Market size and forecast, by formulation
9.4.13.4.Market size and forecast, by application
9.4.13.5.Market size and forecast, by distribution channel
9.4.14.Philippines
9.4.14.1.Market size and forecast, by product type
9.4.14.2.Market size and forecast, by container type
9.4.14.3.Market size and forecast, by formulation
9.4.14.4.Market size and forecast, by application
9.4.14.5.Market size and forecast, by distribution channel
9.4.15.Rest of Asia-Pacific
9.4.15.1.Market size and forecast, by product type
9.4.15.2.Market size and forecast, by container type
9.4.15.3.Market size and forecast, by formulation
9.4.15.4.Market size and forecast, by application
9.4.15.5.Market size and forecast, by distribution channel
9.5.MIDDLE EAST
9.5.1.Key market trends and opportunities
9.5.2.Market size and forecast, by product type
9.5.3.Market size and forecast, by container type
9.5.4.Market size and forecast, by formulation
9.5.5.Market size and forecast, by application
9.5.6.Market size and forecast, by distribution channel
9.5.7.Market size and forecast, by Country
9.5.8.UAE
9.5.8.1.Market size and forecast, by product type
9.5.8.2.Market size and forecast, by container type
9.5.8.3.Market size and forecast, by formulation
9.5.8.4.Market size and forecast, by application
9.5.8.5.Market size and forecast, by distribution channel
9.5.9.Saudi Arabia
9.5.9.1.Market size and forecast, by product type
9.5.9.2.Market size and forecast, by container type
9.5.9.3.Market size and forecast, by formulation
9.5.9.4.Market size and forecast, by application
9.5.9.5.Market size and forecast, by distribution channel
9.5.10.Palestine
9.5.10.1.Market size and forecast, by product type
9.5.10.2.Market size and forecast, by container type
9.5.10.3.Market size and forecast, by formulation
9.5.10.4.Market size and forecast, by application
9.5.10.5.Market size and forecast, by distribution channel
9.5.11.Jordan
9.5.11.1.Market size and forecast, by product type
9.5.11.2.Market size and forecast, by container type
9.5.11.3.Market size and forecast, by formulation
9.5.11.4.Market size and forecast, by application
9.5.11.5.Market size and forecast, by distribution channel
9.5.12.Bahrein
9.5.12.1.Market size and forecast, by product type
9.5.12.2.Market size and forecast, by container type
9.5.12.3.Market size and forecast, by formulation
9.5.12.4.Market size and forecast, by application
9.5.12.5.Market size and forecast, by distribution channel
9.5.13.Qatar
9.5.13.1.Market size and forecast, by product type
9.5.13.2.Market size and forecast, by container type
9.5.13.3.Market size and forecast, by formulation
9.5.13.4.Market size and forecast, by application
9.5.13.5.Market size and forecast, by distribution channel
9.5.14.Azerbaijan
9.5.14.1.Market size and forecast, by product type
9.5.14.2.Market size and forecast, by container type
9.5.14.3.Market size and forecast, by formulation
9.5.14.4.Market size and forecast, by application
9.5.14.5.Market size and forecast, by distribution channel
9.5.15.Georgia
9.5.15.1.Market size and forecast, by product type
9.5.15.2.Market size and forecast, by container type
9.5.15.3.Market size and forecast, by formulation
9.5.15.4.Market size and forecast, by application
9.5.15.5.Market size and forecast, by distribution channel
9.5.16.Iraq
9.5.16.1.Market size and forecast, by product type
9.5.16.2.Market size and forecast, by container type
9.5.16.3.Market size and forecast, by formulation
9.5.16.4.Market size and forecast, by application
9.5.16.5.Market size and forecast, by distribution channel
9.5.17.Pakistan
9.5.17.1.Market size and forecast, by product type
9.5.17.2.Market size and forecast, by container type
9.5.17.3.Market size and forecast, by formulation
9.5.17.4.Market size and forecast, by application
9.5.17.5.Market size and forecast, by distribution channel
9.5.18.Kuwait
9.5.18.1.Market size and forecast, by product type
9.5.18.2.Market size and forecast, by container type
9.5.18.3.Market size and forecast, by formulation
9.5.18.4.Market size and forecast, by application
9.5.18.5.Market size and forecast, by distribution channel
9.5.19.Israel
9.5.19.1.Market size and forecast, by product type
9.5.19.2.Market size and forecast, by container type
9.5.19.3.Market size and forecast, by formulation
9.5.19.4.Market size and forecast, by application
9.5.19.5.Market size and forecast, by distribution channel
9.5.20.Kazakhstan
9.5.20.1.Market size and forecast, by product type
9.5.20.2.Market size and forecast, by container type
9.5.20.3.Market size and forecast, by formulation
9.5.20.4.Market size and forecast, by application
9.5.20.5.Market size and forecast, by distribution channel
9.5.21.Rest of Middle East
9.5.21.1.Market size and forecast, by product type
9.5.21.2.Market size and forecast, by container type
9.5.21.3.Market size and forecast, by formulation
9.5.21.4.Market size and forecast, by application
9.5.21.5.Market size and forecast, by distribution channel
9.6.NORTH AFRICA
9.6.1.Key market trends and opportunities
9.6.2.Market size and forecast, by product type
9.6.3.Market size and forecast, by container type
9.6.4.Market size and forecast, by formulation
9.6.5.Market size and forecast, by application
9.6.6.Market size and forecast, by distribution channel
9.6.7.Market size and forecast, by Country
9.6.8.Morocco
9.6.8.1.Market size and forecast, by product type
9.6.8.2.Market size and forecast, by container type
9.6.8.3.Market size and forecast, by formulation
9.6.8.4.Market size and forecast, by application
9.6.8.5.Market size and forecast, by distribution channel
9.6.9.Algeria
9.6.9.1.Market size and forecast, by product type
9.6.9.2.Market size and forecast, by container type
9.6.9.3.Market size and forecast, by formulation
9.6.9.4.Market size and forecast, by application
9.6.9.5.Market size and forecast, by distribution channel
9.6.10.Tunisia
9.6.10.1.Market size and forecast, by product type
9.6.10.2.Market size and forecast, by container type
9.6.10.3.Market size and forecast, by formulation
9.6.10.4.Market size and forecast, by application
9.6.10.5.Market size and forecast, by distribution channel
9.6.11.Libia
9.6.11.1.Market size and forecast, by product type
9.6.11.2.Market size and forecast, by container type
9.6.11.3.Market size and forecast, by formulation
9.6.11.4.Market size and forecast, by application
9.6.11.5.Market size and forecast, by distribution channel
9.6.12.Egypt
9.6.12.1.Market size and forecast, by product type
9.6.12.2.Market size and forecast, by container type
9.6.12.3.Market size and forecast, by formulation
9.6.12.4.Market size and forecast, by application
9.6.12.5.Market size and forecast, by distribution channel
9.6.13.Rest of North Africa
9.6.13.1.Market size and forecast, by product type
9.6.13.2.Market size and forecast, by container type
9.6.13.3.Market size and forecast, by formulation
9.6.13.4.Market size and forecast, by application
9.6.13.5.Market size and forecast, by distribution channel
CHAPTER 10:COMPANY PROFILES
10.1.SANTEN PHARMACEUTICAL
10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.Business performance
10.1.7.Key strategic moves and developments
10.2.BAUSCH & LOMB
10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.Business performance
10.2.7.Key strategic moves and developments
10.3.ALLERGAN
10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Operating business segments
10.3.5.Product portfolio
10.3.6.Business performance
10.3.7.Key strategic moves and developments
10.4.ABBOTT LABORATORIES
10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Operating business segments
10.4.5.Product portfolio
10.4.6.Business performance
10.4.7.Key strategic moves and developments
10.5.JOHNSON & JOHNSON
10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Operating business segments
10.5.5.Product portfolio
10.5.6.Business performance
10.5.7.Key strategic moves and developments
10.6.LUMECARE
10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Operating business segments
10.6.5.Product portfolio
10.6.6.Business performance
10.6.7.Key strategic moves and developments
10.7.SIMILASAN CORPORATION
10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Operating business segments
10.7.5.Product portfolio
10.7.6.Business performance
10.7.7.Key strategic moves and developments
10.8.URSAPHARM
10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Operating business segments
10.8.5.Product portfolio
10.8.6.Business performance
10.8.7.Key strategic moves and developments
10.9.NOVARTIS AG (ALCON)
10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Operating business segments
10.9.5.Product portfolio
10.9.6.Business performance
10.9.7.Key strategic moves and developments
10.10.OCUSOFT
10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.Business performance
10.10.7.Key strategic moves and developments
Note:
o*Details on financial performance and strategic moves and developments may not be captured for unlisted companies.
o*List of companies profiled in this TOC is tentative and may change after detailed analysis.
o*Market size and forecast will be provided from 2019-2027, and forecast period would be 2020-2027.
LIST OF TABLES
TABLE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 2.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 3.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, BY REGION, 2019-2027 ($MILLION)
TABLE 4.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, BY REGION, 2019-2027 ($MILLION)
TABLE 5.OTC ARTIFICIAL TEARS MARKET FOR GEL, BY REGION, 2019-2027 ($MILLION)
TABLE 6.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 7.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 8.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 9.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 11.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 12.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 13.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, BY REGION, 2019-2027 ($MILLION)
TABLE 14.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 15.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 16.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION 2019-2027 ($MILLION)
TABLE 17.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 18.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 19.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION 2019-2027 ($MILLION)
TABLE 20.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, BY REGION, 2019-2027 ($MILLION)
TABLE 21.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, BY REGION, 2019-2027 ($MILLION)
TABLE 22.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 23.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, BY REGION, 2019-2027 ($MILLION)
TABLE 24.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, BY REGION, 2019-2027 ($MILLION)
TABLE 25.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 26.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 27.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 28.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 29.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 30.OTC ARTIFICIAL TEARS MARKET FOR , BY REGION, , 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 33.NORTH AMERICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 34.NORTH AMERICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 35.NORTH AMERICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 36.NORTH AMERICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 37.EUROPE OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 38.EUROPE OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 39.EUROPE OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 40.EUROPE OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 41.EUROPE OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 42.EUROPE OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 43.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 44.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 45.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 46.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 47.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 48.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 49.MIDDLE EAST OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 50.MIDDLE EAST OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 51.MIDDLE EAST OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 52.MIDDLE EAST OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 53.MIDDLE EAST OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 54.MIDDLE EAST OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 55.NORTH AFRICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 56.NORTH AFRICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 57.NORTH AFRICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 58.NORTH AFRICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 59.NORTH AFRICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 60.NORTH AFRICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 61.SANTEN PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 62.SANTEN PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 63.BAUSCH & LOMB: COMPANY SNAPSHOT
TABLE 64.BAUSCH & LOMB: OPERATING SEGMENTS
TABLE 65.ALLERGAN: COMPANY SNAPSHOT
TABLE 66.ALLERGAN: OPERATING SEGMENTS
TABLE 67.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 68.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 69.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 70.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 71.LUMECARE: COMPANY SNAPSHOT
TABLE 72.LUMECARE: OPERATING SEGMENTS
TABLE 73.SIMILASAN CORPORATION: COMPANY SNAPSHOT
TABLE 74.SIMILASAN CORPORATION: OPERATING SEGMENTS
TABLE 75.URSAPHARM: COMPANY SNAPSHOT
TABLE 76.URSAPHARM: OPERATING SEGMENTS
TABLE 77.NOVARTIS AG (ALCON): COMPANY SNAPSHOT
TABLE 78.NOVARTIS AG (ALCON): OPERATING SEGMENTS
TABLE 79.OCUSOFT: COMPANY SNAPSHOT
TABLE 80.OCUSOFT: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET SEGMENTATION
FIGURE 2.TOP INVESTMENT POCKET
FIGURE 3.TOP WINNING STRATEGIES (%)
FIGURE 4.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, 2019-2027 ($MILLION)
FIGURE 5.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, 2019-2027 ($MILLION)
FIGURE 6.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, 2019-2027 ($MILLION)
FIGURE 7.OTC ARTIFICIAL TEARS MARKET FOR GEL, 2019-2027 ($MILLION)
FIGURE 8.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, 2019-2027 ($MILLION)
FIGURE 9.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, 2019-2027 ($MILLION)
FIGURE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 11.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, 2019-2027 ($MILLION)
FIGURE 12.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, 2019-2027 ($MILLION)
FIGURE 13.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 14.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, 2019-2027 ($MILLION)
FIGURE 15.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, 2019-2027 ($MILLION)
FIGURE 16.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, 2019-2027 ($MILLION)
FIGURE 17.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, 2019-2027 ($MILLION)
FIGURE 18.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, 2019-2027 ($MILLION)
FIGURE 19.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, 2019-2027 ($MILLION)
FIGURE 20.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 21.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 22.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, 2019-2027 ($MILLION)
FIGURE 23.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, 2019-2027 ($MILLION)
FIGURE 24.GLOBAL OTC ARTIFICIAL TEARS, BY REGION, 2019 (%)
FIGURE 25.U.S. OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 26.REST OF NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 27.UK OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 28.GERMANY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 29.FRANCE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 30.ITALY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 31.SPAIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 32.POLAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 33.REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 34.JAPAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 35.CHINA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 36.INDIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 37.MALAYSIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 38.VIETNAM OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 39.THAILAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 40.PHILIPPINES OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 42.UAE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 43.SAUDI ARABIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 44.PALESTINE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 45.JORDAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 46.BAHREIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 47.QATAR OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 48.AZERBAIJAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 49.GEORGIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 50.IRAQ OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 51.PAKISTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 52.KUWAIT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 53.ISRAEL OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 54.KAZAKHSTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 55.REST OF MIDDLE EAST OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 56.MOROCCO OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 57.ALGERIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 58.TUNISIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 59.LIBIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 60.EGYPT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
FIGURE 61.REST OF NORTH AFRICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)